Late treatment effects—not so much the virus—threaten new HIV patients
People diagnosed with sexually transmitted HIV in the industrialized world today have no greater risk of death within five years than the general population, according to the latest report from the multicenter European CASCADE study.
Those still at somewhat greater risk:
* Intravenous drug users
* People not treated immediately with the HAART regimen.
* In general, men compared with women.
Patients may yet face some excess mortality risk, starting a decade after they first show evidence of anti-HIV antibodies. This is probably due to the cardiac effects of the treatment regimen.
Related searches
CASCADE Collaboration HIV (Other results from the European study)
DAD study HIV (First evidence of heart risks from antiviral drugs)
SMART study HIV (Why restricting antivirals because of this risk is a bad idea)
CME
Find a free government-sponsored online CME course about HIV management.
Practice Guidelines
Find recent guidelines from the New York State Department of Health that address HIV management in primary care.
These guidelines give special attention to management of anxiety and depression, including increased risk of suicide, in this patient population.
Research/Reviews
Look to this category for more information about HAART toxicity.
